EPS for Ardelyx, Inc. (ARDX) Expected At $-0.40; Taubman Centers, Inc. (TCO) Covered By 4 Bullish Analysts Last Week

April 26, 2018 - By William Brooks

Ardelyx, Inc. (NASDAQ:ARDX) Logo

Among 19 analysts covering Taubman Centers Inc. (NYSE:TCO), 4 have Buy rating, 1 Sell and 14 Hold. Therefore 21% are positive. Taubman Centers Inc. had 35 analyst reports since July 21, 2015 according to SRatingsIntel. BTIG Research initiated the shares of TCO in report on Thursday, August 25 with “Neutral” rating. As per Monday, September 18, the company rating was downgraded by Morgan Stanley. The firm earned “Equal-Weight” rating on Thursday, February 16 by Morgan Stanley. The rating was initiated by BMO Capital Markets with “Sell” on Monday, September 11. The rating was downgraded by Evercore on Monday, November 16 to “Hold”. JP Morgan downgraded the stock to “Neutral” rating in Tuesday, September 26 report. Oppenheimer upgraded Taubman Centers, Inc. (NYSE:TCO) on Monday, August 24 to “Outperform” rating. The firm earned “Hold” rating on Monday, September 25 by Jefferies. Jefferies maintained the shares of TCO in report on Wednesday, August 23 with “Hold” rating. The rating was upgraded by BMO Capital Markets to “Market Perform” on Wednesday, December 13. See Taubman Centers, Inc. (NYSE:TCO) latest ratings:

16/02/2018 Broker: Mizuho Rating: Hold New Target: $63.0 Maintain
13/02/2018 Broker: Sandler O’Neill Rating: Hold New Target: $63.0 Maintain
13/02/2018 Broker: Citigroup Old Rating: Neutral New Rating: Neutral Old Target: $58 New Target: $61 Maintain
09/01/2018 Broker: BMO Capital Markets Rating: Hold New Target: $62.0 Maintain
22/12/2017 Broker: Jefferies Rating: Hold New Target: $56.0 Maintain
13/12/2017 Broker: BMO Capital Markets Old Rating: Underperform New Rating: Market Perform Old Target: $48 Upgrade
08/11/2017 Broker: Mizuho Old Rating: Buy New Rating: Neutral Downgrade

Analysts expect Ardelyx, Inc. (NASDAQ:ARDX) to report $-0.40 EPS on May, 4.They anticipate $0.19 EPS change or 32.20% from last quarter’s $-0.59 EPS. After having $0.21 EPS previously, Ardelyx, Inc.’s analysts see -290.48% EPS growth. The stock increased 1.03% or $0.05 during the last trading session, reaching $4.9. About 189,796 shares traded. Ardelyx, Inc. (NASDAQ:ARDX) has declined 60.67% since April 26, 2017 and is downtrending. It has underperformed by 72.22% the S&P500.

Ardelyx, Inc. develops and sells therapeutics for the treatment of cardio renal and gastrointestinal diseases in the United States. The company has market cap of $233.26 million. The Company’s lead product candidate is tenapanor, which is in Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial for the treatment of hyperphosphatemia in end-stage renal disease patients on dialysis. It currently has negative earnings. The firm is also developing RDX7675, which is in Phase III clinical trial for the treatment of people with hyperkalemia; and RDX8940 in Phase I clinical trial for the treatment of patients with NASH and other gastrointestinal indications.

Among 7 analysts covering Ardelyx Inc (NASDAQ:ARDX), 7 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Ardelyx Inc had 16 analyst reports since August 18, 2015 according to SRatingsIntel. BTIG Research initiated it with “Buy” rating and $33 target in Friday, December 18 report. The stock has “Buy” rating by Cantor Fitzgerald on Friday, March 16. The firm has “Buy” rating given on Monday, August 28 by Cantor Fitzgerald. The firm has “Buy” rating by Wedbush given on Thursday, October 12. The firm has “Market Outperform” rating given on Wednesday, March 9 by JMP Securities. Cantor Fitzgerald maintained the shares of ARDX in report on Thursday, October 12 with “Overweight” rating. The rating was maintained by Citigroup with “Buy” on Friday, October 13. As per Wednesday, August 10, the company rating was maintained by Citigroup. On Thursday, March 31 the stock rating was initiated by Ladenburg Thalmann with “Buy”. BTIG Research initiated Ardelyx, Inc. (NASDAQ:ARDX) rating on Tuesday, September 22. BTIG Research has “Buy” rating and $33 target.

Since December 13, 2017, it had 1 buying transaction, and 5 selling transactions for $5.70 million activity. Wolff David A. also sold $20,657 worth of Taubman Centers, Inc. (NYSE:TCO) on Tuesday, December 19. On Tuesday, February 13 HATKOFF CRAIG M sold $79,137 worth of Taubman Centers, Inc. (NYSE:TCO) or 1,350 shares. Shares for $2.19 million were sold by TAUBMAN WILLIAM S. 58,000 shares were sold by TAUBMAN ROBERT S, worth $3.64M on Wednesday, December 13. Marakovits Cornelia Connelly bought 4,000 shares worth $253,400.

Investors sentiment increased to 1.28 in Q4 2017. Its up 0.06, from 1.22 in 2017Q3. It is positive, as 30 investors sold Taubman Centers, Inc. shares while 63 reduced holdings. 54 funds opened positions while 65 raised stakes. 65.43 million shares or 15.75% more from 56.53 million shares in 2017Q3 were reported. Royal Comml Bank Of Canada owns 9,818 shares. Schroder Management Grp Inc holds 0% in Taubman Centers, Inc. (NYSE:TCO) or 7,633 shares. Alps Advsrs Incorporated invested in 3,542 shares. American Century Companies holds 0.01% or 113,816 shares in its portfolio. State Street holds 2.76M shares. Pnc Financial Grp Inc invested in 0.01% or 87,114 shares. Ameritas Inv Prtnrs holds 0.05% or 18,162 shares in its portfolio. Dimensional Fund Advisors L P has invested 0.03% in Taubman Centers, Inc. (NYSE:TCO). Walleye Trading Ltd Co stated it has 63,082 shares or 0.02% of all its holdings. Employees Retirement Association Of Colorado holds 14,033 shares or 0.01% of its portfolio. Blackrock Incorporated reported 6.66M shares. Sarasin Prns Llp has 39,304 shares for 0.05% of their portfolio. Mutual Of America Capital Management Llc has 49,909 shares for 0.05% of their portfolio. Australia-based Macquarie Grp Ltd has invested 0.02% in Taubman Centers, Inc. (NYSE:TCO). Jane Street Grp Incorporated Lc holds 21,591 shares or 0% of its portfolio.

The stock increased 0.94% or $0.5 during the last trading session, reaching $53.83. About 250,538 shares traded. Taubman Centers, Inc. (NYSE:TCO) has declined 12.94% since April 26, 2017 and is downtrending. It has underperformed by 24.49% the S&P500.

Taubman Centers, Inc. operates as a real estate investment trust. The company has market cap of $4.63 billion. As of June 30, 2005, the firm owned a 63% managing general partnerÂ’s interest in The Taubman Realty Group Limited Partnership . It has a 59.35 P/E ratio. The operating partnership engages in the ownership, management, leasing, acquisition, development, and expansion of regional retail shopping centers and interests therein.

Taubman Centers, Inc. (NYSE:TCO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 William Brooks

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: